1. Background
2. Methods
| Number | Primer Name | Oligo Sequences 5' → 3' |
|---|---|---|
| Sequence 5' → 3' (10-50 bp)* | ||
| 1 | BAX forward | 5′-GATGGCAACTTCAACTGGGG-3′ |
| 2 | BAX reverse | 5′-AGCCACCCTGGTCTTGGAT-3′ |
| 3 | BCL2 forward | 5′-TGGCCTTCTTTGAGTTCGGT-3′ |
| 4 | BCL2 reverse | 5′-AGTTCCACAAAGGCATCCCAG-3′ |
| 5 | β-actin forward | 5′-ATGGTGGGTATGGGTCAGAAGG-3′ |
| 6 | β-actin reverse | 5′- TGGCTGGGGTGTTGAAGGTC -3′ |
3. Results
Hematoxylin-eosin staining in experimental groups 21 days after the last administration; Black and white arrows showing the telogenic and anagenic hair follicles, respectively; A, Grape sap-treated group (10 mg/kg); B, Grape sap-treated group (100 mg/kg); C, untreated group receiving bleomycin 21 days after the last administration (×20 magnification), arrow showing the telogenic hair follicle; D, Normal saline group 21 days after the last administration (×20 magnification), arrow showing the anagenic hair follicle (×10 magnification).
Mean number of hair follicles in 1500 μm in experimental groups on days 7, 14, and 21; there were significant differences between the experimental groups and the bleomycin-treated group in terms of the number of hair follicles (P < 0.001, P < 0.01, and P < 0.05). The results are presented as mean ± standard error of the mean and evaluated using a two-way analysis of variance.
Total antioxidant capacity (antioxidant absorption coefficient) in experimental groups on days 7, 14, and 21; there were significant differences between the experimental groups and the bleomycin-treated group in terms of total antioxidant capacity (P < 0.001, P < 0.01, and P < 0.05). The results are presented as mean ± standard error of the mean and evaluated using a two-way analysis of variance.
Mean BCL2 gene expression in experimental groups on days 7, 14, and 21; there were significant differences between the grape sap-treated groups and the bleomycin-treated group (P < 0.001, P < 0.01, and P < 0.05). The results are presented as mean ± standard error of the mean and evaluated using a two-way analysis of variance. With regard to the results of real-time polymerase chain reaction, a significant increase was observed in terms of BAX expression.
Mean BAX gene expression in experimental groups on days 7, 14, and 21; the results were significant in the bleomycin-treated group. There were significant differences between the experimental groups and the normal saline group in terms of mean BAX expression (P < 0.001, P < 0.01, and P < 0.05). The results are presented as mean ± standard error of the mean and evaluated using a two-way analysis of variance.




